Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J9214
    Short Description Interferon alfa-2b inj
    Long Description Injection, interferon, alfa-2b, recombinant, 1 million units
    Pricing indicator 51
    Coverage code D
    ASC payment group code YY
    BETOS2 code O1D
    Action code N
    Type of service G
    Effective date 2009-01-01
    Date Added 1993-01-01

    Drug Details

    • Interferon alfa-2b injection is used to treat a number of conditions.

    • Interferon alfa-2b injection is used

      • alone or in combination with ribavirin (Copegus, Rebetol, Ribasphere) to treat chronic (long-term) hepatitis C infection (swelling of the liver caused by a virus) in people who show signs of liver damage,

      • to treat chronic hepatitis B infection (swelling of the liver caused by a virus) in people who show signs of liver damage,

      • to treat hairy cell leukemia (a white blood cell cancer),

      • to treat genital warts,

      • to treat Kaposi's sarcoma (a type of cancer that causes abnormal tissue to grow on different parts of the body) related to acquired immunodeficiency syndrome (AIDS),

      • to treat malignant melanoma (a cancer that begins in certain skin cells) in certain people who have had surgery to remove the cancer,

      • along with another medication to treat follicular non-Hodgkin's lymphoma (NHL; a slow-growing blood cancer).

    • Interferon alfa-2b is in a class of medications called immunomodulators. Interferon alfa-2b works to treat hepatitis C virus (HCV) and hepatitis B virus (HBV) by decreasing the amount virus in the body. Interferon alfa-2b may not cure hepatitis B or hepatitis C or prevent you from developing complications from these infections such as cirrhosis (scarring) of the liver, liver failure, or liver cancer. It also may not prevent the spread of hepatitis B or C to other people. It is not known exactly how interferon alfa-2b works to treat cancer or genital warts.